Tali Cukierman-Yaffe

Medicine & Life Sciences

1. Type 2 Diabetes Mellitus 100%
2. Cognitive Dysfunction 90%
3. Cognition 86%
4. Glucose 75%
5. Dementia 43%
6. Mental Status and Dementia Tests 41%
7. Insulin Glargine 39%
8. Pediatric Obesity 38%
9. Type 1 Diabetes Mellitus 33%
10. Hypoglycemia 32%
11. Gestational Diabetes 30%
12. Glucose Intolerance 29%
13. Fasting 26%
14. Systematic Reviews 26%
15. dulaglutide 24%
16. Morbid Obesity 24%
17. Thyroid Diseases 23%
18. Overweight 23%
19. Obesity 23%
20. Insulin 23%
21. Eye Diseases 21%
22. Body Mass Index 21%
23. Randomized Controlled Trials 20%
24. Cardiovascular Diseases 20%
25. Pregnancy 20%
26. Cohort Studies 18%
27. Pharmacovigilance 18%
28. Population 18%
29. Diabetic Foot 16%
30. Young Adult 16%
31. Incidence 15%
32. Meta-Analysis 15%
33. Blood Pressure 15%
34. Israel 15%
35. Omega-3 Fatty Acids 15%
36. Lost to Follow-Up 15%
37. Therapeutics 15%
38. Glucose Tolerance Test 14%
39. Odds Ratio 14%
40. Feasibility Studies 14%
41. Mothers 14%
42. Telmisartan 14%
43. Disease Management 14%
44. Diabetes Mellitus 13%
45. Self Care 13%
46. Diabetes Complications 13%
47. Health 13%
48. Intelligence 13%
49. Thyroid-Stimulating Immunoglobulins 12%
50. Vascular Dementia 12%